Actively Recruiting
Genetics of Appendix Cancer Study
Led by Andreana Holowatyj, PhD, MSCI · Updated on 2025-04-18
700
Participants Needed
1
Research Sites
624 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
CONDITIONS
Official Title
Genetics of Appendix Cancer Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Known diagnosis of appendix cancer in the United States
- Mentally and physically able to consent and participate in the study
- Diagnosed by or consulting with a physician/clinical provider participating in the GAP Study
- Biological parents (mother and/or father) of individuals actively participating in the GAP Study
- Residing in the United States
You will not qualify if you...
- Women pregnant at the time of consent
- Prisoners
- Unable to provide informed consent
- Unable to read, write, or complete questionnaires in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
G
GAP Study Coordinator (Rebecca B.)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here